Conclusion
The pathophysiology of coagulopathy in the trauma patient is complex and multifactorial. The term ‘DIC’ is incorrectly used to define trauma-related coagulopathy. Although the routine laboratory results resemble those of DIC because they detect activation of coagulation and fibrinolysis and consumption of platelets and coagulation factors, the pathophysiology of the coagulopathy is quite different. While DIC reflects a hypercoagulable state with loss of localization of the coagulation process, leading to diffuse deposition of fibrin, trauma-related coagulopathy is a hypocoagulable state with fibrin deposition limited to the site of injury. The use of the right terms is not only a semantic issue but has major implications for treatment. In fact this was the main reason for the delay in introduction of rFVIIa to trauma patients a few years after its introduction to hemophilia and bleeding disorders: The use of agents markedly enhancing hemostasis, such as rFVIIa, in patients already suffering from a hypercoagulable state seemed to be risky. Much of the early data in the literature are not applicable due to the change of blood components and transfusion policy in the modern area of trauma patient resuscitation. A multidisciplinary approach involving anesthesiologists, transfusion specialists, hematologists, laboratory specialists and surgeons is required for the diagnosis and treatment of traumatic bleeding.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hoyt DB (2004) Clinical review of bleeding dilemmas in trauma. Semin Hematol 41 (suppl 1):40–43
MacLeod JBA (2003) Early coagulopathy predicts mortality in trauma. J Trauma 55:39–44
Brohi K (2003) Acute traumatic coagulopathy. J Trauma 541:1127–1130
Gando S, Nakanishi Y, Tedo I (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction syndrome. Crit Care Med 23:1835–1842
MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M (2003) Early coagulopathy predicts mortality in trauma. J Trauma 55:39–44
Risberg B, Medegard A, Heideman M (1986) Early activation of humoral proteolytic systems in patients with multiple trauma. Crit Care Med 13:917–925
Gando S, Nanzaki S, Morimoto Y (1999) Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma 47:719–723
Ordog GJ, Wasserberger J, Balasubramanium S (1985) Coagulation abnormalities in traumatic shock. Ann Emerg Med 14:650–655
Farkash U, Lynn M, Scope A (2002) Does prehospital fluid administration impact core body temperature and coagulation functions in combat casualties? Injury 33:103–110
Lynn M, Jeroukhimov I, Klein Y, Martinowitz U (2002) Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 28 (suppl 2):S241–S247
Wolberg AS, Meng ZH, Monroe DM, Hoffman M (2004) A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56:1221–1228
Monroe DM, Hoffman M, Roberts HR (1996) Transmission of a procoagulant signal from tissue factor-bearing cells to platelets. Blood Coagul Fibrinolysis 7:459–464
Watts DD, Trask A, Soeken K, Perdue P, Dols S, Kaufmann C (1998) Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 44:846–854
Reed RL II, Johnson TD, Hudson JD, Fischer RP (1992) The disparity between hypothermic coagulopathy and clotting studies. J Trauma 33:465–470
Reed RL II, Bracey AW Jr, Hudson JD, Miller TA, Fischer RP (1990) Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels. Circ Shock 32:141–152
Martini WZ, Pusateri AE, Uscilowicz JM, Delgado AV, Holcomb JB (2005) Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 58:1002–1010
Broersma RJ, Bullemer GD, Mammen EF (1970) Acidosis induced disseminated intravascular microthrombosis and its dissolution by streptokinase. Thromb Diath Haemorrh 24:55–67
Meng ZH, Wolberg AS, Monroe DM III, Hoffman M (2003) The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 55:886–891
Dutton RP, Hess JR, Scalea TM (2003) Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 15:184–188
Valles J, Santos MT, Aznar J (2002) Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood 99:3978–3984
Valles J, Santos MT, Aznar J, Velert M, Barbera G, Carmena R (1997) Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes 46:1047–1053
Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM (1999) Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 81:400–406
Santos MT, Valles J, Aznar J, Marcus AJ, Broekman MJ, Safier LB (1997) Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation 95:63–68
Tangelder GJ, Teirlinck HC, Slaaf DW, Reneman RS (1985) Distribution of blood platelets flowing in arterioles. Am J Physiol 248:H318–323
Ouaknine-Orlando B, Samama CM, Riou B (1999) Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 90:1454–1461
Teirlinck HC, Tangelder GJ, Slaaf DW, Muijtjens AM, Arts T, Reneman RS (1984) Orientation and diameter distribution of rabbit blood platelets flowing in small arterioles. Biorheology 21:317–331
Blajchman MA, Bordin JO, Bardossy L, Heddle NM (1994) The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol 86:347–350
Scolar G, Garrido M, Mazzara R, Castillo R, Ordinas A (1988) Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 28:406–411
Ho CH (1998) The hemostatic effect of packed red cell transfusion in patients with anemia. Transfusion 38:1011–1014
Valeri CR, Cassidy G, Pivacek LE (2001) Anemia induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 41:977–983
Martinowitz U, Michaelson M (2005) Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 3:1–9
Veldman A, Homan M, Ehrenforth S (2003) New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr Med Chem 10:797–811
Martinowitz U, Holcomb JB, Pusateri AE, et al (2001) Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 50:721–729
Gando S (2001) Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost 27:585–592
Nielsen VG, Lyerly RT 3rd, Gurley WQ (2004) The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 99:1587–1592
Mortier E, Ongenae M, De BL (1997) In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 52:1061–1064
Van Breugel HF, de Groot PG, Heethaar RM, Sixma JJ (1992) Role of plasma viscosity in platelet adhesion. Blood 80:953–959
Gagnon DR, Zhang TJ, Brand FN, Kannel WB (1994) Hematocrit and the risk of cardiovascular disease — the Framingham study: a 34-year follow-up. Am Heart J 127:674–682
Mortelmans YJ, Vermaut G, Verbruggen AM (1995) Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg 81:1235–1242
Mardel SN, Saunders FM, Allen H (1998) Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80:204–207
Boldt J, Muller M, Heesen M, Heyn O, Hempelmann G (1996) Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med 22:1075–1081
Innerhofer P, Fries D, Margreiter J (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95:858–865
Haynes GR, Bailey MK (2000) Excessive use of hetastarch: an iatrogenic cause of bleeding and hypocalcemia? Anesth Analg 90:1455–1456
Hardy JF, De Moerloose P, Samama M (2004) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anesth 51: 4, 293–310
Hiippala S (1998) Replacement of massive blood loss. Vox Sang 74 (suppl 2):399–407
Simmons RL, Collins JA, Heisterkamp CA 3rd, Mills DE, Andren R, Phillips LL (1969) Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. III. Post-resuscitative changes. Ann Surg 169:455–482
Stainsby D, MacLennan S, Hamilton PJ (2000) Management of massive blood loss: a template guideline. Br J Anaesth 85:487–491
Hiippala ST, Myllyla GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360–365
Miller RD, Robbins TO, Tong MJ, Barton SL (1971) Coagulation defects associated with massive blood transfusions. Ann Surg 174:794–801
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mayo, A., Martinowitz, U., Kluger, Y. (2006). Coagulopathy in the Critically Injured Patient. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33396-7_22
Download citation
DOI: https://doi.org/10.1007/3-540-33396-7_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30155-4
Online ISBN: 978-3-540-33396-8
eBook Packages: MedicineMedicine (R0)